MBL Wealth’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$790K Sell
3,326
-26
-0.8% -$5.4K 0.05% 161
2026
Q1
$708K Buy
3,352
+47
+1% +$10.1K 0.05% 156
2025
Q4
$679K Buy
+3,305
New +$622K 0.05% 158
2023
Q1
Sell
-3,025
Closed -$233K 165
2022
Q4
$233K Sell
3,025
-500
-14% -$38K 0.04% 147
2022
Q3
$235K Sell
3,525
-500
-12% -$31.7K 0.05% 137
2022
Q2
$210K Sell
4,025
-96
-2% -$5.46K 0.05% 137
2022
Q1
$234K Buy
+4,121
New +$221K 0.06% 149
2021
Q1
$578K Buy
9,515
+10
+0.1% +$552 0.2% 76
2020
Q4
$509K Buy
+9,505
New +$493K 0.2% 73

Other funds holding CAH

MBL Wealth's CAH Position: Q2 2026 in Review

MBL Wealth reduced its Cardinal Health (CAH) stake by 0.78% in Q2 2026, selling an estimated $5.4K and leaving 3,326 shares worth $790K. The position accounts for 0.05% of the portfolio, ranked #161.

MBL Wealth first reported a position in CAH in Q4 2020 and has held it in 9 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • MBL Wealth held 3,326 shares of Cardinal Health worth $790K as of Q2 2026.
  • MBL Wealth sold 26 Cardinal Health shares in Q2 2026, an estimated $5.4K.
  • Cardinal Health made up 0.05% of MBL Wealth's portfolio in Q2 2026, its #161 holding.
  • MBL Wealth first reported a position in Cardinal Health in Q4 2020 and has held it in 9 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.